<VariationArchive RecordType="classified" VariationID="4211" VariationName="NM_181458.4(PAX3):c.365_369del (p.Lys122fs)" VariationType="Deletion" Accession="VCV000004211" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="19250" VariationID="4211">
      <GeneList>
        <Gene Symbol="PAX3" FullName="paired box 3" GeneID="5077" HGNC_ID="HGNC:8617" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q36.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="222199887" stop="222298998" display_start="222199887" display_stop="222298998" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="223064605" stop="223163714" display_start="223064605" display_stop="223163714" Strand="-" />
          </Location>
          <OMIM>606597</OMIM>
          <Haploinsufficiency last_evaluated="2020-05-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PAX3">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-05-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PAX3">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_181458.4(PAX3):c.365_369del (p.Lys122fs)</Name>
      <CanonicalSPDI>NC_000002.12:222295609:TCTTTT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q36.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="222295610" stop="222295614" display_start="222295610" display_stop="222295614" variantLength="5" positionVCF="222295609" referenceAlleleVCF="CTCTTT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="223160329" stop="223160333" display_start="223160329" display_stop="223160333" variantLength="5" positionVCF="223160328" referenceAlleleVCF="CTCTTT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>K122fs</ProteinChange>
      <ProteinChange>K121fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011632.1" sequenceAccession="NG_011632" sequenceVersion="1" change="g.8368_8372del">
            <Expression>NG_011632.1:g.8368_8372del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_021186.1" sequenceAccession="NG_021186" sequenceVersion="1" change="g.2465_2469del">
            <Expression>NG_021186.1:g.2465_2469del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000438.6" sequenceAccession="NM_000438" sequenceVersion="6" change="c.365_369del">
            <Expression>NM_000438.6:c.365_369del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000429.2" sequenceAccession="NP_000429" sequenceVersion="2" change="p.Lys122fs">
            <Expression>NP_000429.2:p.Lys122fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127366.3" sequenceAccession="NM_001127366" sequenceVersion="3" change="c.362_366del">
            <Expression>NM_001127366.3:c.362_366del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001120838.1" sequenceAccession="NP_001120838" sequenceVersion="1" change="p.Lys121fs">
            <Expression>NP_001120838.1:p.Lys121fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_013942.5" sequenceAccession="NM_013942" sequenceVersion="5" change="c.365_369del">
            <Expression>NM_013942.5:c.365_369del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_039230.1" sequenceAccession="NP_039230" sequenceVersion="1" change="p.Lys122fs">
            <Expression>NP_039230.1:p.Lys122fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181457.4" sequenceAccession="NM_181457" sequenceVersion="4" change="c.365_369del">
            <Expression>NM_181457.4:c.365_369del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_852122.1" sequenceAccession="NP_852122" sequenceVersion="1" change="p.Lys122fs">
            <Expression>NP_852122.1:p.Lys122fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181458.4" sequenceAccession="NM_181458" sequenceVersion="4" change="c.365_369del" MANESelect="true">
            <Expression>NM_181458.4:c.365_369del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_852123.1" sequenceAccession="NP_852123" sequenceVersion="1" change="p.Lys122fs">
            <Expression>NP_852123.1:p.Lys122fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.223160330_223160334del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.223160330_223160334del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.222295611_222295615del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.222295611_222295615del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181459.4" sequenceAccession="NM_181459" sequenceVersion="4" change="c.365_369del">
            <Expression>NM_181459.4:c.365_369del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_852124.1" sequenceAccession="NP_852124" sequenceVersion="1" change="p.Lys122fs">
            <Expression>NP_852124.1:p.Lys122fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181460.4" sequenceAccession="NM_181460" sequenceVersion="4" change="c.365_369del">
            <Expression>NM_181460.4:c.365_369del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_852125.1" sequenceAccession="NP_852125" sequenceVersion="1" change="p.Lys122fs">
            <Expression>NP_852125.1:p.Lys122fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181461.4" sequenceAccession="NM_181461" sequenceVersion="4" change="c.365_369del">
            <Expression>NM_181461.4:c.365_369del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_852126.1" sequenceAccession="NP_852126" sequenceVersion="1" change="p.Lys122fs">
            <Expression>NP_852126.1:p.Lys122fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="606597.0008" DB="OMIM" />
        <XRef Type="rs" ID="1559318562" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_181458.4(PAX3):c.365_369del (p.Lys122fs) AND Waardenburg syndrome type 1" Accession="RCV000004431" Version="2">
        <ClassifiedConditionList TraitSetID="1162">
          <ClassifiedCondition DB="MedGen" ID="C1847800">Waardenburg syndrome type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1995-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1995-01-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">1308353</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7897628</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8423616</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1162" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4496" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Waardenburg's syndrome type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">WAARDENBURG SYNDROME WITH DYSTOPIA CANTHORUM</ElementValue>
                <XRef Type="MIM" ID="193500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Waardenburg syndrome type 1</ElementValue>
                <XRef ID="Waardenburg+syndrome+type+1/7424" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008670" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PAX3</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">WS1</ElementValue>
                <XRef Type="MIM" ID="193500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Waardenburg syndrome type I (WS1) is an auditory-pigmentary disorder comprising congenital sensorineural hearing loss and pigmentary disturbances of the iris, hair, and skin, along with dystopia canthorum (lateral displacement of the inner canthi). The hearing loss in WS1, observed in approximately 60% of affected individuals, is congenital, typically non-progressive, either unilateral or bilateral, and sensorineural. Most commonly, hearing loss in WS1 is bilateral and profound (&gt;100 dB). The majority of individuals with WS1 have either a white forelock or early graying of the scalp hair before age 30 years. The classic white forelock observed in approximately 45% of individuals is the most common hair pigmentation anomaly seen in WS1. Affected individuals may have complete heterochromia iridium, partial/segmental heterochromia, or hypoplastic or brilliant blue irides. Congenital leukoderma is frequently seen on the face, trunk, or limbs.</Attribute>
                <XRef ID="NBK1531" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5519" />
                <XRef ID="5519" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301703</ID>
                <ID Source="BookShelf">NBK1531</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG, 2002">
                <ID Source="pmc">3110944</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG, 2014">
                <ID Source="PubMed">24651602</ID>
              </Citation>
              <XRef ID="894" DB="Orphanet" />
              <XRef ID="C1847800" DB="MedGen" />
              <XRef ID="MONDO:0008670" DB="MONDO" />
              <XRef Type="MIM" ID="193500" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="24604" SubmissionDate="2013-03-15" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="606597.0008_WAARDENBURG SYNDROME TYPE 1" title="PAX3, 5-BP DEL, EX5_WAARDENBURG SYNDROME TYPE 1" />
        <ClinVarAccession Accession="SCV000024604" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1995-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">'Splotch' is an established mouse model for neural tube defects (NTD). Furthermore, in the human, neural tube defects are occasionally associated with Waardenburg syndrome (Carezani-Gavin et al., 1992; Chatkupt et al., 1993). Hol et al. (1995) screened the PAX3 gene in 39 patients with familial NTD, using single-strand conformation analysis. One patient with lumbosacral meningomyelocele was found to have a 5-bp deletion in exon 5, approximately 55 bp upstream of the conserved homeodomain. The deletion of CAA (gln) and TC caused a frameshift with a stop codon almost immediately after the mutated site; the frameshift led to the insertion of an arg residue before the creation of the stop codon. The patient was found to show mild signs of WS1 (193500). Varying signs of this syndrome were found to cosegregate with the mutation in the family. The results supported the hypothesis that mutations in the gene for PAX3 can also predispose to NTD. It is noteworthy that whereas homozygous Splotch mouse embryos can have NTD, in the heterozygous state mutations of the PAX3 gene do not cause but seem to predispose to NTD in a strain-specific manner.</Attribute>
              <Citation>
                <ID Source="PubMed">1308353</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">8423616</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">7897628</ID>
              </Citation>
              <XRef DB="OMIM" ID="193500" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PAX3" />
          </GeneList>
          <Name>PAX3, 5-BP DEL, EX5</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">5-BP DEL, EX5</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606597.0008" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">WAARDENBURG SYNDROME TYPE 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="24604" TraitType="Disease" MappingType="Name" MappingValue="WAARDENBURG SYNDROME TYPE 1" MappingRef="Preferred">
        <MedGen CUI="C1847800" Name="Waardenburg syndrome type 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

